Article

California governor vetoes bill that would have reduced licensing requirements to perfom eye surgery

Author(s):

AB 2236 would have allowed optometrists to perform anterior segment laser and minor procedures which involve the use of a scalpel or injections.

California Gov. Gavin Newsom this week vetoed AB 2236, which would have reduced the medical education, clinical, and surgical training requirements to become licensed in California to perform eye surgery.

The proposal would have allowed optometrists to perform anterior segment laser and minor procedures which involve the use of a scalpel or injections.

Gov. Gavin Newsom

Gov. Gavin Newsom

“I am not convinced that the education and training required is sufficient to prepare optometrists to perform the surgical procedures identified,” Newsom wrote in the veto to the general assembly. “This bill would allow optometrists to perform advanced surgical procedures with less than one year of training.

In comparison, Newsom noted in the statement that physicians who perform these procedures must complete at least a three-year residency program.

“For this reason, I cannot sign this bill,” Newsom wrote.

During a panel discussion at the Eyecelerator event at the American Academy of Ophthalmology’s 2022 annual meeting at McCormick Place in Chicago, Stephen McLeod, CEO of the AAO, noted that Newsom’s veto helps to ensure patient safety.

Several other groups had stepped up to oppose the measure.

In opposing AB 2236, the California Medical Association pointed out that the measure did not require adequate training to assure competency of candidates who would be certified to perform these procedures, and actually has loopholes that undermine the training requirements of the bill.

The American Society of Retina Specialists and Safe Eyes America had also stepped up to voice their opposition prior to a vote on the proposal, pointing out that a reduction in surgical licensing requirements would be detrimental to patient surgical outcomes and safety.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.